Machine learning in chemoinformatics and drug discovery.
暂无分享,去创建一个
Russ B Altman | Yu-Chen Lo | Wen Torng | Stefano E. Rensi | Stefano E Rensi | R. Altman | Y. Lo | Wen Torng
[1] J. Friedman,et al. A Statistical View of Some Chemometrics Regression Tools , 1993 .
[2] Z. Deng,et al. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. , 2006, Journal of medicinal chemistry.
[3] Lawrence D. Jackel,et al. Handwritten Digit Recognition with a Back-Propagation Network , 1989, NIPS.
[4] David B. Searls,et al. Data integration: challenges for drug discovery , 2005, Nature Reviews Drug Discovery.
[5] Vijay S. Pande,et al. Molecular graph convolutions: moving beyond fingerprints , 2016, Journal of Computer-Aided Molecular Design.
[6] Tao Huang,et al. MOST: most-similar ligand based approach to target prediction , 2017, BMC Bioinformatics.
[7] Igor I. Baskin,et al. Machine Learning Methods for Property Prediction in Chemoinformatics: Quo Vadis? , 2012, J. Chem. Inf. Model..
[8] J. Bajorath,et al. Advancing the activity cliff concept , 2013 .
[9] Russ B. Altman,et al. 3D deep convolutional neural networks for amino acid environment similarity analysis , 2017, BMC Bioinformatics.
[10] Alexander Chuprina,et al. Drug- and Lead-likeness, Target Class, and Molecular Diversity Analysis of 7.9 Million Commercially Available Organic Compounds Provided by 29 Suppliers , 2010, J. Chem. Inf. Model..
[11] Paola Gramatica,et al. Introduction General Considerations , 2022 .
[12] Alexandre Varnek,et al. Transductive Support Vector Machines: Promising Approach to Model Small and Unbalanced Datasets , 2013, Molecular informatics.
[13] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[14] J V Gobburu,et al. Artificial neural networks as a novel approach to integrated pharmacokinetic-pharmacodynamic analysis. , 1996, Journal of pharmaceutical sciences.
[15] Guixia Liu,et al. Performance Evaluation of 2D Fingerprint and 3D Shape Similarity Methods in Virtual Screening , 2012, J. Chem. Inf. Model..
[16] Bin Chen,et al. Comparison of Random Forest and Pipeline Pilot Naïve Bayes in Prospective QSAR Predictions , 2012, J. Chem. Inf. Model..
[17] José L. Medina-Franco,et al. Visualization of Molecular Fingerprints , 2011, J. Chem. Inf. Model..
[18] J. Devillers. Prediction of mammalian toxicity of organophosphorus pesticides from QSTR modeling , 2004, SAR and QSAR in environmental research.
[19] Roberto Todeschini,et al. Towards Global QSAR Model Building for Acute Toxicity: Munro Database Case Study , 2014, International journal of molecular sciences.
[20] J. A. Grant,et al. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.
[21] J. Friedman,et al. [A Statistical View of Some Chemometrics Regression Tools]: Response , 1993 .
[22] Matthias W. Seeger,et al. Gaussian Processes For Machine Learning , 2004, Int. J. Neural Syst..
[23] Maykel Pérez González,et al. Quantitative structure-activity relationship studies of HIV-1 integrase inhibition. 1. GETAWAY descriptors. , 2007, European journal of medicinal chemistry.
[24] Yoshua Bengio,et al. Generative Adversarial Nets , 2014, NIPS.
[25] K. Marill. Advanced statistics: linear regression, part II: multiple linear regression. , 2004, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[26] Thomas Blaschke,et al. The rise of deep learning in drug discovery. , 2018, Drug discovery today.
[27] William Stafford Noble,et al. Support vector machine , 2013 .
[28] Robert Damoiseaux,et al. 3D Chemical Similarity Networks for Structure-Based Target Prediction and Scaffold Hopping. , 2016, ACS chemical biology.
[29] Jameed Hussain,et al. Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets , 2010, J. Chem. Inf. Model..
[30] Fernanda Borges,et al. Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors. , 2013, European journal of medicinal chemistry.
[31] Russ B Altman,et al. Shallow Representation Learning via Kernel PCA Improves QSAR Modelability , 2017, J. Chem. Inf. Model..
[32] Hengzhi Liu,et al. QSAR Study of Ethyl 2‐[(3‐Methyl‐2,5‐dioxo(3‐pyrrolinyl))amino] ‐4‐(trifluoromethyl)pyrimidine‐5‐carboxylate: An Inhibitor of AP‐1 and NF‐ϰB Mediated Gene Expression Based on Support Vector Machines. , 2003 .
[33] Yoshua Bengio,et al. Neural Machine Translation by Jointly Learning to Align and Translate , 2014, ICLR.
[34] I M Kapetanovic,et al. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. , 2008, Chemico-biological interactions.
[35] Dumitru Erhan,et al. Going deeper with convolutions , 2014, 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[36] Erkki Oja,et al. Independent component analysis: algorithms and applications , 2000, Neural Networks.
[37] Hugo Kubinyi,et al. Evolutionary variable selection in regression and PLS analyses , 1996 .
[38] Robert P. Sheridan,et al. Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..
[39] S. Wold,et al. Comparative molecular field analysis , 1991 .
[40] Geoffrey E. Hinton,et al. Speech recognition with deep recurrent neural networks , 2013, 2013 IEEE International Conference on Acoustics, Speech and Signal Processing.
[41] Kathrin Heikamp,et al. Large-Scale Similarity Search Profiling of ChEMBL Compound Data Sets , 2011, J. Chem. Inf. Model..
[42] Jürgen Bajorath,et al. Molecular Similarity Concepts for Informatics Applications. , 2017, Methods in molecular biology.
[43] Zakariya Yahya Algamal,et al. High‐dimensional QSAR prediction of anticancer potency of imidazo[4,5‐b]pyridine derivatives using adjusted adaptive LASSO , 2015 .
[44] Yoshihiro Yamanishi,et al. Benchmarking a Wide Range of Chemical Descriptors for Drug‐Target Interaction Prediction Using a Chemogenomic Approach , 2014, Molecular informatics.
[45] Qin Tong,et al. Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictions. , 2012, Molecular pharmaceutics.
[46] Geoffrey E. Hinton,et al. ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.
[47] Mutasem O. Taha,et al. Elaborate Ligand-Based Modeling Coupled with Multiple Linear Regression and k Nearest Neighbor QSAR Analyses Unveiled New Nanomolar mTOR Inhibitors , 2013, J. Chem. Inf. Model..
[48] P. Labute,et al. Binary Quantitative Structure—Activity Relationship (QSAR) Analysis of Estrogen Receptor Ligands. , 1999 .
[49] Yotam Hechtlinger,et al. A Generalization of Convolutional Neural Networks to Graph-Structured Data , 2017, ArXiv.
[50] Russ B. Altman,et al. Flexible Analog Search with Kernel PCA Embedded Molecule Vectors , 2017, Computational and structural biotechnology journal.
[51] Weida Tong,et al. Mold2, Molecular Descriptors from 2D Structures for Chemoinformatics and Toxicoinformatics , 2008, J. Chem. Inf. Model..
[52] Anton J. Hopfinger,et al. 4D-QSAR: Perspectives in Drug Design , 2010, Molecules.
[53] Jens Meiler,et al. Autocorrelation descriptor improvements for QSAR: 2DA_Sign and 3DA_Sign , 2016, Journal of Computer-Aided Molecular Design.
[54] Andreas Bender,et al. "Bayes Affinity Fingerprints" Improve Retrieval Rates in Virtual Screening and Define Orthogonal Bioactivity Space: When Are Multitarget Drugs a Feasible Concept? , 2006, J. Chem. Inf. Model..
[55] Igor V Tetko,et al. A renaissance of neural networks in drug discovery , 2016, Expert opinion on drug discovery.
[56] Alan R. Katritzky,et al. Quantum-Chemical Descriptors in QSAR/QSPR Studies , 1996 .
[57] Amanda C. Schierz. Virtual screening of bioassay data , 2009, J. Cheminformatics.
[58] M. Mohammadhosseini,et al. QSAR study of VEGFR-2 inhibitors by using genetic algorithm-multiple linear regressions (GA-MLR) and genetic algorithm-support vector machine (GA-SVM): a comparative approach , 2015, Medicinal Chemistry Research.
[59] A. E. Hoerl,et al. Ridge regression: biased estimation for nonorthogonal problems , 2000 .
[60] Igor I. Baskin,et al. The continuous molecular fields approach to building 3D-QSAR models , 2013, Journal of Computer-Aided Molecular Design.
[61] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[62] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[63] David DeCaprio,et al. Cheminformatics approaches to analyze diversity in compound screening libraries. , 2010, Current opinion in chemical biology.
[64] Denis Fourches,et al. Characterizing the Chemical Space of ERK2 Kinase Inhibitors Using Descriptors Computed from Molecular Dynamics Trajectories , 2017, J. Chem. Inf. Model..
[65] Peter Willett,et al. Promoting Access to White Rose Research Papers Effectiveness of Graph-based and Fingerprint-based Similarity Measures for Virtual Screening of 2d Chemical Structure Databases , 2022 .
[66] Sergey Nikolenko,et al. druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico. , 2017, Molecular pharmaceutics.
[67] Yong Huang,et al. Large-Scale Chemical Similarity Networks for Target Profiling of Compounds Identified in Cell-Based Chemical Screens , 2015, PLoS Comput. Biol..
[68] Jeremy G. Vinter,et al. FieldScreen: Virtual Screening Using Molecular Fields. Application to the DUD Data Set , 2008, J. Chem. Inf. Model..
[69] P. Seiler,et al. Steric and lipophobic components of the hydrophobic fragmental constant. , 1981, Arzneimittel-Forschung.
[70] Wee Kiang Yeo,et al. Extraction and validation of substructure profiles for enriching compound libraries , 2012, Journal of Computer-Aided Molecular Design.
[71] Igor I Baskin,et al. Chemoinformatics as a Theoretical Chemistry Discipline , 2011, Molecular informatics.
[72] Shane Legg,et al. Human-level control through deep reinforcement learning , 2015, Nature.
[73] Roberto Todeschini,et al. Defining a novel k-nearest neighbours approach to assess the applicability domain of a QSAR model for reliable predictions , 2013, Journal of Cheminformatics.
[74] Robert Damoiseaux,et al. Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential , 2017, Scientific Reports.
[75] Alexander Tropsha,et al. Using Graph Indices for the Analysis and Comparison of Chemical Datasets , 2013, Molecular informatics.
[76] Thomas Blaschke,et al. Molecular de-novo design through deep reinforcement learning , 2017, Journal of Cheminformatics.
[77] Igor I. Baskin,et al. A Neural Device for Searching Direct Correlations Between Structures and Properties of Chemical Compounds. , 2010 .
[78] V. Poroikov,et al. Robustness of Biological Activity Spectra Predicting by Computer Program PASS for Noncongeneric Sets of Chemical Compounds , 2000, Journal of chemical information and computer sciences.
[79] Geoffrey E. Hinton,et al. Deep Learning , 2015, Nature.
[80] J. Bajorath. Selected Concepts and Investigations in Compound Classification, Molecular Descriptor Analysis, and Virtual Screening , 2001 .
[81] Alán Aspuru-Guzik,et al. Convolutional Networks on Graphs for Learning Molecular Fingerprints , 2015, NIPS.
[82] R. García-Domenech,et al. Some new trends in chemical graph theory. , 2008, Chemical reviews.
[83] João D. Ferreira,et al. Semantic Similarity for Automatic Classification of Chemical Compounds , 2010, PLoS Comput. Biol..
[84] Nasser M. Nasrabadi,et al. Pattern Recognition and Machine Learning , 2006, Technometrics.
[85] Danishuddin,et al. Descriptors and their selection methods in QSAR analysis: paradigm for drug design. , 2016, Drug discovery today.
[86] Thierry Kogej,et al. Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks , 2017, ACS central science.
[87] B. Fan,et al. Molecular similarity and diversity in chemoinformatics: From theory to applications , 2006, Molecular Diversity.
[88] Max Welling,et al. Auto-Encoding Variational Bayes , 2013, ICLR.
[89] Jitender Verma,et al. 3D-QSAR in drug design--a review. , 2010, Current topics in medicinal chemistry.
[90] Robert P Sheridan,et al. Why do we need so many chemical similarity search methods? , 2002, Drug discovery today.
[91] Jérôme Hert,et al. New Methods for Ligand-Based Virtual Screening: Use of Data Fusion and Machine Learning to Enhance the Effectiveness of Similarity Searching , 2006, J. Chem. Inf. Model..
[92] J. Aubé,et al. Butitaxel analogues: synthesis and structure-activity relationships. , 1997, Journal of medicinal chemistry.
[93] Alexander Tropsha,et al. Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.
[94] J. Dearden,et al. QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.
[95] Hugo Kubinyi,et al. Free Wilson Analysis. Theory, Applications and its Relationship to Hansch Analysis , 1988 .
[96] J. Bajorath,et al. Recent Advances in Scaffold Hopping. , 2017, Journal of medicinal chemistry.
[97] John MacCuish,et al. Chemoinformatics applications of cluster analysis , 2014 .